174 related articles for article (PubMed ID: 38742159)
1. The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific.
Ahn YM; Maddumage JC; Grant EJ; Chatzileontiadou DSM; Perera WWJG; Baker BM; Szeto C; Gras S
Curr Res Struct Biol; 2024; 7():100148. PubMed ID: 38742159
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity.
Yajima Y; Kosaka A; Ohkuri T; Hirohashi Y; Li D; Nagasaki T; Nagato T; Torigoe T; Kobayashi H
Heliyon; 2023 Sep; 9(9):e20192. PubMed ID: 37809871
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.
Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J
J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783
[TBL] [Abstract][Full Text] [Related]
4. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
[TBL] [Abstract][Full Text] [Related]
6. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
Sankaranarayanan S; Mohkhedkar M; Janakiraman V
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.
Takagi A; Matsui M
Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174
[TBL] [Abstract][Full Text] [Related]
8. Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1-BA.5 Peptides by HLA Molecules.
Nersisyan SA; Shkurnikov MY; Zhiyanov AP; Novosad VO; Tonevitsky AG
Dokl Biochem Biophys; 2022 Dec; 507(1):298-301. PubMed ID: 36786990
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-specific CD8
Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
[TBL] [Abstract][Full Text] [Related]
10. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules.
Nersisyan S; Zhiyanov A; Zakharova M; Ishina I; Kurbatskaia I; Mamedov A; Galatenko A; Shkurnikov M; Gabibov A; Tonevitsky A
PeerJ; 2022; 10():e13354. PubMed ID: 35502206
[TBL] [Abstract][Full Text] [Related]
11. Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals.
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AA
bioRxiv; 2021 Dec; ():. PubMed ID: 34909772
[TBL] [Abstract][Full Text] [Related]
12. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
13. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
[TBL] [Abstract][Full Text] [Related]
14. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
[TBL] [Abstract][Full Text] [Related]
15. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
Akkız H
Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8
Lopes-Ribeiro Á; Oliveira PM; Retes HM; Barbosa-Stancioli EF; da Fonseca FG; Tsuji M; Coelho-Dos-Reis JGA
Front Immunol; 2023; 14():1229712. PubMed ID: 38022506
[TBL] [Abstract][Full Text] [Related]
17. Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8
Wang Y; Yang L; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Zhang Y; Zhuang R; Ma Y
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257752
[TBL] [Abstract][Full Text] [Related]
18. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4
Chen Y; Mason GH; Scourfield DO; Greenshields-Watson A; Haigh TA; Sewell AK; Long HM; Gallimore AM; Rizkallah P; MacLachlan BJ; Godkin A
Cell Rep; 2023 Aug; 42(8):112827. PubMed ID: 37471227
[TBL] [Abstract][Full Text] [Related]
19. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
Guo E; Guo H
PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
[TBL] [Abstract][Full Text] [Related]
20. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
